Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations

Clinical trial NCT01392703 · COMPLETED

Trial details

NCT number

NCT01392703

Sponsor

Bristol-Myers Squibb

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-07-01

Primary completion

2011-09-01

Enrollment

141

View on ClinicalTrials.gov